You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma

 

Online download statistics by month:

Online download statistics by month: October 2020 to June 2025

AbstractFullPdf
Oct 202010410438
Nov 2020169169101
Dec 2020858542
Jan 202112012066
Feb 2021595960
Mar 2021808047
Apr 2021656533
May 2021353526
Jun 2021404025
Jul 2021404031
Aug 2021373736
Sep 2021424222
Oct 2021434339
Nov 2021373732
Dec 2021262621
Jan 2022353921
Feb 2022212122
Mar 2022525228
Apr 2022404122
May 2022363624
Jun 2022384022
Jul 2022373919
Aug 2022383815
Sep 20222323217
Oct 2022485011
Nov 2022292910
Dec 2022282817
Jan 2023343416
Feb 2023606018
Mar 2023181941
Apr 2023242524
May 2023313320
Jun 2023191912
Jul 2023484825
Aug 2023232411
Sep 202319194
Oct 2023292910
Nov 2023373716
Dec 2023343411
Jan 2024222311
Feb 202414149
Mar 2024383977
Apr 2024535353
May 2024434317
Jun 20244747153
Jul 2024677021
Aug 2024323216
Sep 2024212117
Oct 2024363619
Nov 2024131411
Dec 2024171724
Jan 2025353521
Feb 202510310321
Mar 2025404030
Apr 2025494931
May 2025303036
Jun 2025424227
Total248525071849